GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

Last update: 12 hours ago

75.51

0.31 (0.41%)

  • 1D 0.41%
  • 5D -0.58%
  • 1M 2.15%
  • 6M -10.91%
  • YTD -3.66%
  • 1Y -4.59%
  • 5Y 25.85%
Previous Close 75.20
Open 75.95
Volume 2,555,131
Avg. Volume (3M) 4,475,660
Market Cap 34,574,897,152
Price / Earnings (TTM) 15.86
Price / Earnings (Forward) 18.48
Price / Sales 1.74
Price / Book 3.75
52 Weeks Range
57.65 (-23%) — 94.80 (25%)
Earnings Date 30 Jul 2025
TTM Dividend Yield 0.17%
Profit Margin 11.03%
Operating Margin (TTM) 14.78%
Diluted EPS (TTM) 4.76
Quarterly Revenue Growth (YOY) 2.70%
Quarterly Earnings Growth (YOY) 50.80%
Total Debt/Equity (MRQ) 97.51%
Current Ratio (MRQ) 0.980
Operating Cash Flow (TTM) 1.78 B
Levered Free Cash Flow (TTM) 1.58 B
Return on Assets (TTM) 5.87%
Return on Equity (TTM) 26.44%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Mixed Mixed
Health Information Services (Global) Mixed Mixed
Stock GE HealthCare Technologies Inc. Bullish Bearish

AIStockmoo Score

1.1
Analyst Consensus 1.5
Insider Activity NA
Price Volatility 2.0
Technical Moving Averages -1.0
Technical Oscillators 2.0
Average 1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
GEHC 35 B 0.17% 15.86 3.75
TEM 10 B - - 32.36
HQY 9 B - 74.57 4.16
WAY 7 B - 297.08 2.14
RCM 6 B - - 2.14
PRVA 3 B - 191.25 3.98

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
Sector Healthcare
Industry Health Information Services
Investment Style Mid Core
% Held by Insiders 0.28%
% Held by Institutions 80.65%
52 Weeks Range
57.65 (-23%) — 94.80 (25%)
Price Target Range
73.00 (-3%) — 89.00 (17%)
High 89.00 (Wells Fargo, 17.87%) Buy
89.00 (Citigroup, 17.87%) Buy
Median 85.00 (12.57%)
Low 73.00 (UBS, -3.32%) Hold
Average 83.43 (10.49%)
Total 5 Buy, 2 Hold
Avg. Price @ Call 68.55
Firm Date Target Price Call Price @ Call
Citigroup 09 Jul 2025 89.00 (17.87%) Buy 75.51
30 Apr 2025 86.00 (13.89%) Buy 70.33
Morgan Stanley 06 May 2025 78.00 (3.30%) Hold 67.09
UBS 05 May 2025 73.00 (-3.32%) Hold 69.37
Evercore ISI Group 01 May 2025 85.00 (12.57%) Buy 67.67
Goldman Sachs 01 May 2025 82.00 (8.59%) Buy 67.67
Wells Fargo 01 May 2025 89.00 (17.87%) Buy 67.67
Piper Sandler 23 Apr 2025 88.00 (16.54%) Buy 64.89

No data within this time range.

  • 3M
Date Type Details
07 Jul 2025 Announcement GE HealthCare to announce second quarter 2025 results on July 30, 2025
01 Jul 2025 Announcement GE HealthCare announces cash dividend for second quarter of 2025
24 Jun 2025 Announcement FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
23 Jun 2025 Announcement GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
21 Jun 2025 Announcement GE HealthCare drives innovation in theranostics with latest technological advances
20 Jun 2025 Announcement AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape
19 Jun 2025 Announcement Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
12 Jun 2025 Announcement GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions
02 Jun 2025 Announcement PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
30 May 2025 Announcement Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer
16 May 2025 Announcement New Healthcare AI Models Could Reshape Everything From Burnout to Diagnostics
15 May 2025 Announcement GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite
13 May 2025 Announcement GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent
13 May 2025 Announcement GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
12 May 2025 Announcement GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system
05 May 2025 Announcement AI Healthcare Boom Gains Speed as Regulators and Innovators Align
02 May 2025 Announcement ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
30 Apr 2025 Announcement GE HealthCare reports first quarter 2025 financial results
28 Apr 2025 Announcement GE HealthCare management to present at upcoming investor conferences
24 Apr 2025 Announcement GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
17 Apr 2025 Announcement GE HealthCare to announce first quarter 2025 results on April 30, 2025
10 Apr 2025 Announcement Cincinnati Children’s and GE HealthCare build collaborative research program to drive pediatric imaging innovation
Show more
TTM Dividend Yield 0.17%
2Y Average Dividend Yield 0.13%
Payout Ratio 2.63%
Expected Next Dividend Payment Feb 2026
Ex Date Announcement Date Payment Date Details
25 Jul 2025 01 Jul 2025 15 Aug 2025 0.035 Cash
25 Apr 2025 27 Mar 2025 15 May 2025 0.035 Cash
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 Cash
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 Cash
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 Cash
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 Cash
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 Cash
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 Cash
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 Cash
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 Cash

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2025 0.105 3 0.14
2024 0.120 4 0.15
2023 0.090 3 0.12

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria